Percutaneous Hemodynamic Support With Impella 2.5 During Scar-related Ventricular Tachycardia Ablation

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

January 31, 2012

Conditions
Ventricular Tachycardia
Interventions
DEVICE

Circulatory Support System

Femoral angiography will be performed, and if the anatomy is suitable, the femoral artery preclosure technique will be employed. The Impella 2.5 will be inserted through th femoral artery into the left ventricle. Anti-coagulation will be titrated to achieve a therapeutic ACT level. Organ perfusion and Hemodynamic data will be collected during simulated VTs and throughout the course of the case. The performance level of the device may be adjusted during the case to quantify hemodynamic effects

Trial Locations (1)

10029

Mount Sinai School of Medicine, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abiomed Inc.

INDUSTRY

lead

Vivek Reddy

OTHER

NCT01294267 - Percutaneous Hemodynamic Support With Impella 2.5 During Scar-related Ventricular Tachycardia Ablation | Biotech Hunter | Biotech Hunter